↓ Skip to main content

Targeting microRNAs as key modulators of tumor immune response

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
151 Dimensions

Readers on

mendeley
157 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting microRNAs as key modulators of tumor immune response
Published in
Journal of Experimental & Clinical Cancer Research, June 2016
DOI 10.1186/s13046-016-0375-2
Pubmed ID
Authors

Laura Paladini, Linda Fabris, Giulia Bottai, Carlotta Raschioni, George A. Calin, Libero Santarpia

Abstract

The role of immune response is emerging as a key factor in the complex multistep process of cancer. Tumor microenvironment contains different types of immune cells, which contribute to regulate the fine balance between anti and protumor signals. In this context, mechanisms of crosstalk between cancer and immune cells remain to be extensively elucidated. Interestingly, microRNAs (miRNAs) have been demonstrated to function as crucial regulators of immune response in both physiological and pathological conditions. Specifically, different miRNAs have been reported to have a role in controlling the development and the functions of tumor-associated immune cells. This review aims to describe the most important miRNAs acting as critical modulators of immune response in the context of different solid tumors. In particular, we discuss recent studies that have demonstrated the existence of miRNA-mediated mechanisms regulating the recruitment and the activation status of specific tumor-associated immune cells in the tumor microenvironment. Moreover, various miRNAs have been found to target key cancer-related immune pathways, which concur to mediate the secretion of immunosuppressive or immunostimulating factors by cancer or immune cells. Modalities of miRNA exchange and miRNA-based delivery strategies are also discussed. Based on these findings, the modulation of individual or multiple miRNAs has the potential to enhance or inhibit specific immune subpopulations supporting antitumor immune responses, thus contributing to negatively affect tumorigenesis. New miRNA-based strategies can be developed for more effective immunotherapeutic interventions in cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 <1%
Denmark 1 <1%
Unknown 155 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 21%
Student > Ph. D. Student 26 17%
Student > Master 22 14%
Student > Bachelor 22 14%
Student > Doctoral Student 5 3%
Other 13 8%
Unknown 36 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 49 31%
Agricultural and Biological Sciences 24 15%
Medicine and Dentistry 20 13%
Immunology and Microbiology 8 5%
Engineering 4 3%
Other 12 8%
Unknown 40 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2016.
All research outputs
#19,944,994
of 25,374,647 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#1,462
of 2,378 outputs
Outputs of similar age
#268,318
of 367,736 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#11
of 28 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,378 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,736 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.